The renin-angiotensin-aldosterone system (RAAS) is a regulator of blood pressure and cardiovascular function, currently being researched due to COVID-19.

The Relation of Angiotensin-Converting Enzyme 2, Renin-Angiotensin-Aldosterone System Inhibitors, and Arterial Stiffness in Acute COVID-19 Emergency Department Patients—A Prospective ...

ACE inhibitors and angiotensin-receptor blockers have been found to effectively slow progression of kidney disease. It has been theorized that dual blockade of the renin-angiotensin-aldosterone ...

These patients are often prescribed renin–angiotensin–aldosterone system (RAAS) inhibitors, including angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs). This ...

Inhibition of the Renin Angiotensin Aldosterone System in Black Populations -- Does It or Doesn't It Work? Janice G. Douglas, MD. Disclosures. July 07, 2004. In This Article.

Evaluated renin-angiotensin-aldosterone system (RAAS) inhibitor drugs and their maximum doses, listed in descending order of observed frequency at index: lisinopril, 40 mg; losartan, 100 mg ...

INTRODUCTION Various methods of combination renin–angiotensin–aldosterone system blockade help achieve more potent antiproteinuric effects, but may be associated with higher risk of side ...

I would like to respond to 2 statements in the commentary by Quinn and colleagues.[1][1] Angiotensinogen is produced mainly in the liver and fat cells, in response to poor perfusion, and acts as a pro ...

Cite this: Inhibition of the Renin Angiotensin Aldosterone System in Black Populations -- Does It or Doesn't It Work? - Medscape - Jul 08, 2004. Unique Characteristics of Hypertension in Blacks ...